GenMont Biotech

GenMont Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GenMont Biotech (3164.TW) as of Oct 21, 2026 is 57.75 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 40.12 M TWD — a change of 43.95% (higher).

EBITDA

57.75 MTWD

YoY

43.95%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GenMont Biotech is 2025 57.75 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GenMont Biotech was 2024 40.12 M TWD. It decreases by 43.95% higher compared to the previous year.

The GenMont Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
123.80 M TWD
Jan 1, 2019
77.00 M TWD
Jan 1, 2020
77.08 M TWD
Jan 1, 2021
143.58 M TWD
Jan 1, 2022
60.18 M TWD
Jan 1, 2023
6.99 M TWD
Jan 1, 2024
40.12 M TWD
Jan 1, 2025
57.75 M TWD
The GenMont Biotech EBITDA history
YEAREBITDAYoY
57.75 MTWD+43.95%
40.12 MTWD+474.10%
6.99 MTWD-88.39%
60.18 MTWD-58.09%
143.58 MTWD+86.27%
77.08 MTWD+0.11%
77.00 MTWD-37.81%
123.80 MTWD+11.76%
110.77 MTWD+316.31%
26.61 MTWD-1,527.47%
-1.86 MTWD-98.71%
-144.36 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GenMont Biotech Stock analysis

What does GenMont Biotech do? GenMont Biotech Inc. is a biotechnology company based in Tainan, Taiwan, specializing in the research, development, manufacturing, and sale of probiotic supplements. Its products, including various strains of lactobacillus, target immune support against dust allergies and digestive health. The company operates domestically in Taiwan and internationally, having listed on the stock market in 2003. GenMont Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GenMont Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GenMont Biotech is 57.75 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GenMont Biotech changed from 40.12 M TWD to 57.75 M TWD, representing a 43.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) GenMont Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s GenMont Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — GenMont Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GenMont Biotech